Literature DB >> 30977195

Guidance factors orchestrating regulatory T cell positioning in tissues during development, homeostasis, and response.

Thorsten R Mempel1, Francesco Marangoni1.   

Abstract

Over their lifetime, regulatory T cells (Treg) recalibrate their expression of trafficking receptors multiple times as they progress through development, respond to immune challenges, or adapt to the requirements of functioning in various non-lymphoid tissue environments. These trafficking receptors, which include chemokine receptors and other G-protein coupled receptors, integrins, as well as selectins and their ligands, enable Treg not only to enter appropriate tissues from the bloodstream via post-capillary venules, but also to navigate these tissues to locally execute their immune-regulatory functions, and finally to seek out the right antigen-presenting cells and interact with these, in part in order to receive the signals that sustain their survival, proliferation, and functional activity, in part in order to execute their immuno-regulatory function by altering antigen presenting cell function. Here, we will review our current knowledge of when and in what ways Treg alter their trafficking properties. We will focus on the chemokine system and try to identify specialized, non-redundant roles of individual receptors as well as similarities and differences to the conventional T cell compartment.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  T regulatory cells; chemokines; migration; tissue environment; tolerance; trafficking

Mesh:

Substances:

Year:  2019        PMID: 30977195      PMCID: PMC6499397          DOI: 10.1111/imr.12761

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  132 in total

1.  Chemokines define distinct microenvironments in the developing thymus.

Authors:  C C Bleul; T Boehm
Journal:  Eur J Immunol       Date:  2000-12       Impact factor: 5.532

2.  Endoscopic photoconversion reveals unexpectedly broad leukocyte trafficking to and from the gut.

Authors:  Angela M Morton; Esen Sefik; Rabi Upadhyay; Ralph Weissleder; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

3.  The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.

Authors:  Chun-Yang Zhang; Yu Qi; Xiang-Nan Li; Yang Yang; Dong-Lei Liu; Jia Zhao; Deng-Yan Zhu; Kai Wu; Xu-Dong Zhou; Song Zhao
Journal:  Biomed Pharmacother       Date:  2014-12-12       Impact factor: 6.529

4.  Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria.

Authors:  Usriansyah Hadis; Benjamin Wahl; Olga Schulz; Matthias Hardtke-Wolenski; Angela Schippers; Norbert Wagner; Werner Müller; Tim Sparwasser; Reinhold Förster; Oliver Pabst
Journal:  Immunity       Date:  2011-02-17       Impact factor: 31.745

5.  Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

Authors:  Claudio G Brunstein; Jeffrey S Miller; Qing Cao; David H McKenna; Keli L Hippen; Julie Curtsinger; Todd Defor; Bruce L Levine; Carl H June; Pablo Rubinstein; Philip B McGlave; Bruce R Blazar; John E Wagner
Journal:  Blood       Date:  2010-10-15       Impact factor: 22.113

6.  Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.

Authors:  H Hasegawa; A Inoue; M Kohno; J Lei; T Miyazaki; O Yoshie; M Nose; M Yasukawa
Journal:  Gene Ther       Date:  2007-11-08       Impact factor: 5.250

7.  Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.

Authors:  Youn H Kim; Martine Bagot; Lauren Pinter-Brown; Alain H Rook; Pierluigi Porcu; Steven M Horwitz; Sean Whittaker; Yoshiki Tokura; Maarten Vermeer; Pier Luigi Zinzani; Lubomir Sokol; Stephen Morris; Ellen J Kim; Pablo L Ortiz-Romero; Herbert Eradat; Julia Scarisbrick; Athanasios Tsianakas; Craig Elmets; Stephane Dalle; David C Fisher; Ahmad Halwani; Brian Poligone; John Greer; Maria Teresa Fierro; Amit Khot; Alison J Moskowitz; Amy Musiek; Andrei Shustov; Barbara Pro; Larisa J Geskin; Karen Dwyer; Junji Moriya; Mollie Leoni; Jeffrey S Humphrey; Stacie Hudgens; Dmitri O Grebennik; Kensei Tobinai; Madeleine Duvic
Journal:  Lancet Oncol       Date:  2018-08-09       Impact factor: 41.316

8.  Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor.

Authors:  Iris Lee; Liqing Wang; Andrew D Wells; Martin E Dorf; Engin Ozkaynak; Wayne W Hancock
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

9.  Tailoring the homing capacity of human Tregs for directed migration to sites of Th1-inflammation or intestinal regions.

Authors:  R E Hoeppli; K N MacDonald; P Leclair; V C W Fung; M Mojibian; J Gillies; S M R Rahavi; A I M Campbell; S K Gandhi; A M Pesenacker; G Reid; C J Lim; M K Levings
Journal:  Am J Transplant       Date:  2018-06-13       Impact factor: 9.369

10.  CCR4 promotes medullary entry and thymocyte-dendritic cell interactions required for central tolerance.

Authors:  Zicheng Hu; Jessica N Lancaster; Chayanit Sasiponganan; Lauren I R Ehrlich
Journal:  J Exp Med       Date:  2015-09-28       Impact factor: 14.307

View more
  6 in total

Review 1.  Dynamic Roles for IL-2-STAT5 Signaling in Effector and Regulatory CD4+ T Cell Populations.

Authors:  Devin M Jones; Kaitlin A Read; Kenneth J Oestreich
Journal:  J Immunol       Date:  2020-10-01       Impact factor: 5.422

2.  Canonical Secretomes, Innate Immune Caspase-1-, 4/11-Gasdermin D Non-Canonical Secretomes and Exosomes May Contribute to Maintain Treg-Ness for Treg Immunosuppression, Tissue Repair and Modulate Anti-Tumor Immunity via ROS Pathways.

Authors:  Dong Ni; TingTing Tang; Yifan Lu; Keman Xu; Ying Shao; Fatma Saaoud; Jason Saredy; Lu Liu; Charles Drummer; Yu Sun; Wenhui Hu; Jahaira Lopez-Pastrana; Jin J Luo; Xiaohua Jiang; Eric T Choi; Hong Wang; Xiaofeng Yang
Journal:  Front Immunol       Date:  2021-05-18       Impact factor: 7.561

3.  Bcl6 Preserves the Suppressive Function of Regulatory T Cells During Tumorigenesis.

Authors:  Yiding Li; Zhiming Wang; Huayu Lin; Lisha Wang; Xiangyu Chen; Qiao Liu; Qianfei Zuo; Jianjun Hu; Haoqiang Wang; Junyi Guo; Luoyingzi Xie; Jianfang Tang; Zhirong Li; Li Hu; Litian Xu; Xinyuan Zhou; Lilin Ye; Qizhao Huang; Lifan Xu
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

4.  Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and in vitro Expanded iTregs.

Authors:  Zhenzhen Hui; Jiali Zhang; Yu Zheng; Lili Yang; Wenwen Yu; Yang An; Feng Wei; Xiubao Ren
Journal:  Front Immunol       Date:  2021-03-31       Impact factor: 7.561

5.  The oxygen sensor prolyl hydroxylase domain 2 regulates the in vivo suppressive capacity of regulatory T cells.

Authors:  Yousra Ajouaou; Abdulkader Azouz; Anaëlle Taquin; Sebastien Denanglaire; Hind Hussein; Mohammad Krayem; Fabienne Andris; Muriel Moser; Stanislas Goriely; Oberdan Leo
Journal:  Elife       Date:  2022-02-22       Impact factor: 8.713

Review 6.  One, No One, and One Hundred Thousand: T Regulatory Cells' Multiple Identities in Neuroimmunity.

Authors:  Manolo Sambucci; Francesca Gargano; Gisella Guerrera; Luca Battistini; Giovanna Borsellino
Journal:  Front Immunol       Date:  2019-12-20       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.